Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)

  1. Martinón-Torres, F.
  2. Boisnard, F.
  3. Thomas, S.
  4. Sadorge, C.
  5. Borrow, R.
Journal:
Vaccine

ISSN: 1873-2518 0264-410X

Year of publication: 2017

Volume: 35

Issue: 30

Pages: 3764-3772

Type: Article

DOI: 10.1016/J.VACCINE.2017.05.043 GOOGLE SCHOLAR